OCGN ▲ +4.5% - Ocugen, Inc.
$OCGN - Ocugen and Roots Pharmaceutical Complete License Agreement for OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa
14-OCT-2026 06:30 AM ET
Share this post
More filings for $OCGN
OCGN ▲ +4.5% - Ocugen, Inc.Oct 14, 2026OCGN ▼ -0.9% - Ocugen, Inc.Sep 30, 2026OCGN ▲ +1.0% - Ocugen, Inc.Sep 29, 2026OCGN ▲ +2.0% - Ocugen, Inc.Sep 25, 2026OCGN ▲ +0.8% - Ocugen, Inc.Sep 1, 2026OCGN - Ocugen, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $OCGN filing history →💬 Comments
Loading comments…
Leave a comment